Company Alder BioPharmaceuticals, Inc.
Equities
US0143391052
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Anastasiou
PSD | President | 53 | - |
Roger K. Cady
PRN | Corporate Officer/Principal | - | 06/16/06 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 25/18/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 83,637,234 | 73,871,285 ( 88.32 %) | 0 | 88.32 % |
Company contact information
Lundbeck Seattle BioPharmaceuticals, Inc.
11804 North Creek Parkway South
98011, Bothell
+425 205 2900
http://www.alderbio.comSector
1st Jan change | Capi. | |
---|---|---|
+2.93% | 108B | |
+8.82% | 105B | |
+3.03% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |